RxSight Inc’s recent filing unveils that its Director Fountain Tamara unloaded Company’s shares for reported $0.18 million on Mar 12 ’25. In the deal valued at $25.71 per share,7,000 shares were sold. As a result of this transaction, Fountain Tamara now holds 24,793 shares worth roughly $0.36 million.
Then, TAMARA R FOUNTAIN bought 7,000 shares, generating $180,002 in total proceeds.
Before that, Maniar Shweta sold 3,519 shares. RxSight Inc shares valued at $108,618 were divested by the Director at a price of $30.87 per share. As a result of the transaction, Maniar Shweta now holds 7,383 shares, worth roughly $0.11 million.
UBS downgraded its RxSight Inc [RXST] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in early April from “an Overweight” to “an Underweight”. BofA Securities also remained covering RXST and has decreased its forecast on April 03, 2025 with a “an Underperform” recommendation from previously “Buy” rating. Stifel revised its rating on December 20, 2024. It rated RXST as “a Hold” which previously was an “a Buy”.
Price Performance Review of RXST
On Monday, RxSight Inc [NASDAQ:RXST] saw its stock jump 2.41% to $14.42. Over the last five days, the stock has lost -13.18%. RxSight Inc shares have fallen nearly -58.06% since the year began. Nevertheless, the stocks have fallen -73.93% over the past one year. While a 52-week high of $66.54 was reached on 01/07/25, a 52-week low of $13.50 was recorded on 04/11/25. SMA at 50 days reached $26.06, while 200 days put it at $41.21.
Levels Of Support And Resistance For RXST Stock
The 24-hour chart illustrates a support level at 14.06, which if violated will result in even more drops to 13.70. On the upside, there is a resistance level at 14.69. A further resistance level may holdings at 14.97. The Relative Strength Index (RSI) on the 14-day chart is 23.07, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.52, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.25%. Stochastics %K at 4.10% indicates the stock is a buying.
How much short interest is there in RxSight Inc?
A steep rise in short interest was recorded in RxSight Inc stocks on 2025-03-31, growing by 0.53 million shares to a total of 3.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 2.61 million shares. There was a rise of 16.93%, which implies that there is a positive sentiment for the stock.
